Literature DB >> 29420961

The Return of the mTOR Inhibitors: Getting it Right in Patients After Cardiac Transplantation.

Howard J Eisen1, S Farhan Hasni2, Denise Wang2.   

Abstract

Entities:  

Keywords:  cardiac allograft vasculopathy; heart transplantation; mTOR

Mesh：

Substances：

Year:  2018        PMID： 29420961     DOI： 10.1016/j.jacc.2017.12.033

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database.

Authors:  Polydoros N Kampaktsis; Ilias P Doulamis; Rabea Asleh; Elpiniki Makri; Ilias Kalamaras; Christoforos Papastergiopoulos; Maria Emfietzoglou; Anastasis Drosou; Hilmi Alnsasra; Ernesto Ruiz Duque; Alexandros Briasoulis
Journal:  J Am Heart Assoc       Date:  2022-08-24       Impact factor: 6.106

2.  Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection.

Authors:  Kristin Klaeske; Sven Lehmann; Robert Palitzsch; Petra Büttner; Markus J Barten; Khalil Jawad; Sandra Eifert; Diyar Saeed; Michael A Borger; Maja-Theresa Dieterlen
Journal:  Life (Basel)       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.